Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0I5FP
|
|||
| Former ID |
DIB011993
|
|||
| Drug Name |
RHAMM-R3 peptide vaccine
|
|||
| Synonyms |
RHAMM-R3 peptide vaccine (hematological malignancies); RHAMM-R3 peptide vaccine (hematological malignancies), University of Ulm; Receptor for hyaluronic acid-mediated motility peptide vaccine (hematological malignancies), University of Ulm
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1 | [1] | |
| Company |
University of Ulm
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinic... Blood. 2008 Feb 1;111(3):1357-65. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.